Proteins / NOMO3

DarkP69849 · Homo sapiens (Human) · 1222 aa

NOMO3

Nodal modulator 3

AI prediction, not experimentally verified. The function, GO terms and reasoning are generated by a model (BioReason-Pro). Treat them as a hypothesis to test, not as a fact.

Predicted 3D structure

AlphaFold model.

In plain language

NOMO3 has barely been studied. The model's best guess: A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces. By organizing extracellular and membrane-associated complexes, it modulates developmental signaling circuits and likely dampens Notch pathway activity.

Predicted function

A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces.

Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.

Sequence · 1222 aa · coloured by model confidence
1MLVGQGAGPL11GPAVVTAAVV21LLLSGVGPAH31GSEDIVVGCG41GFVKSDVEIN51YSLIEIKLYT61KHGTLKYQTD71CAPNNGYFMI81PLYDKGDFIL91KIEPPLGWSF101EPTTVELHVD111GVSDICTKGG121DINFVFTGFS131VNGKVLSKGQ141PLGPAGVQVS151LRNTGTEAKI161QSTVTQPGGK171FAFFKVLPGD181YEILATHPTW191ALKEASTTVR201VTNSNANAAS211PLIVAGYNVS221GSVRSDGEPM231KGVKFLLFSS241LVTKEDVLGC251NVSPVPGFQP261QDESLVYLCY271TVSREDGSFS281FYSLPSGGYT291VIPFYRGERI301TFDVAPSRLD311FTVEHDSLKI321EPVFHVMGFS331VTGRVLNGPE341GDGVPEAVVT351LNNQIKVKTK361ADGSFRLENI371TTGTYTIHAQ381KEHLYFETVT391IKIAPNTPQL401ADIVATGFSV411CGQISIIRFP421DTVKQMNKYK431VVLSSQDKDK441SLVTVETDAH451GSFCFKANPG461TYKVQVMVPE471AETRAGLTLK481PQTFPLTVTD491RPVMDVAFVQ501FLASVSGKVS511CLDTCGDLLV521TLQSLSRQGE531KRSLQLSGKV541NAMTFTFDNV551LPGKYKISIM561HEDWCWKNKS571LEVEVLEDDV581SAVEFRQTGY591MLRCSLSHAI601TLEFYQDGNG611RENVGIYNLS621KGVNRFCLSK631PGVYKVTPRS641CHRFEQAFYT651YDTSSPSILT661LTAIRHHVLG671TITTDKMMDV681TVTIKSSIDS691EPALVLGPLK701SVQELRREQQ711LAEIEARRQE721REKNGNEEGE731ERMTKPPVQE741MVDELQGPFS751YDFSYWARSG761EKITVTPSSK771ELLFYPPSME781AVVSGESCPG791KLIEIHGKAG801LFLEGQIHPE811LEGVEIVISE821KGASSPLITV831FTDDKGAYSV841GPLHSDLEYT851VTSQKEGYVL861TAVEGTIGDF871KAYALAGVSF881EIKAEDDQPL891PGVLLSLSGG901LFRSNLLTQD911NGILTFSNLS921PGQYYFKPMM931KEFRFEPSSQ941MIEVQEGQNL951KITITGYRTA961YSCYGTVSSL971NGEPEQGVAM981EAVGQNDCSI991YGEDTVTDEE1001GKFRLRGLLP1011GCVYHVQLKA1021EGNDHIERAL1031PHHRVIEVGN1041NDIDDVNIIV1051FRQINQFDLS1061GNVITSSEYL1071PTLWVKLYKS1081ENLDNPIQTV1091SLGQSLFFHF1101PPLLRDGENY1111VVLLDSTLPR1121SQYDYILPQV1131SFTAVGYHKH1141ITLIFNPTRK1151LPEQDIAQGS1161YIALPLTLLV1171LLAGYNHDKL1181IPLLLQLTSR1191LQGVGALGQA1201ASDNSGPEDA1211KRQAKKQKTR1221RT

Protein domains

Known building blocks found by InterPro, placed along the 1222 amino acids of the chain. Hover or tap a block for details.

150100150200250300350400450500550600650700750800850900950100010501100115012001222

Predicted function

Model summary

A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces. By organizing extracellular and membrane-associated complexes, it modulates developmental signaling circuits and likely dampens Notch pathway activity. Its multivalent architecture supports broad protein interactions and transient ribosome association near the cell surface, coupling co-translational handling of secretory clients to the attenuation of receptor–ligand signaling.

Predicted Gene Ontology terms

Molecular function

What it does chemically

Biological process

Which larger process it takes part in

  • GO:0045746 negative regulation of Notch signaling pathway

Cellular component

Where in the cell it sits

Model reasoning

How the model got to its answer

  1. 01

    I begin by dissecting the InterPro architecture and its order along the polypeptide.

    The N-terminus carries IPR055075 (NOMO-like, N-terminal beta-sandwich domain, residues 40–124), immediately followed by an extensive beta-sandwich/Ig-like core: IPR013783 (Immunoglobulin-like fold, residues 122–226) overlaps this region and continues into IPR056189 (NOMO, third transthyretin-like domain, residues 226–325). Mid-chain, there is a second transthyretin/prealbumin-like block: IPR013784 (Carbohydrate-binding-like fold, residues 127–202) overlaps the N-terminal Ig-like region and reinforces a beta-sandwich scaffold; a later carbohydrate-binding-like module appears again (IPR013784, residues 329–403), and this is followed by IPR056190 (NOMO, fifth transthyretin-like domain, residues 409–498). The central-to-distal region continues a series of NOMO-specific transthyretin/prealbumin-like domains—IPR056319 (NOMO, seventh transthyretin-like domain, residues 592–664), IPR056187 (NOMO, eighth prealbumin-like domain, residues 746–798), and IPR055073 (NOMO-like, ninth beta-sandwich domain, residues 799–873)—culminating in a C-terminal module that is characteristic of secreted beta-sandwich proteins: IPR041033 (SpaA-like, prealbumin fold domain subgroup 1, residues 874–955) and IPR013784 (Carbohydrate-binding-like fold, residues 883–954). Immediately downstream sits IPR008969 (Carboxypeptidase-like, regulatory domain superfamily, residues 964–1053), a non-catalytic regulatory fold often used for ligand or partner recognition. The extreme C-terminus is completed by IPR056191 (NOMO, C-terminal transthyretin-like domain, residues 1054–1147). The entire chain is encompassed by IPR051417 (Serine-Aspartate Repeat-Containing family, residues 44–1191), indicating an extended repeat-rich scaffold that favors multivalent binding.

  2. 02

    This ordered array of beta-sandwich and transthyretin/prealbumin-like domains creates a modular, secreted scaffold optimized for avid, multivalent interactions rather than catalysis.

    The repeated NOMO/transthyretin-like modules and Ig-like fold collectively generate broad protein-binding surfaces, directly supporting GO:0005515 protein binding as a core molecular function. The presence of ribosome-engaging beta-sandwich modules and the overall secretory/surface-exposed architecture rationalize GO:0043022 ribosome binding: secreted and membrane-proximal scaffolds can transiently associate with ribosomes at the ER or cell surface to coordinate translation-coupled secretion and to chaperone client proteins.

  3. 03

    From these binding capabilities, I infer a role in signaling modulation.

    The multivalent scaffold can sequester or present ligands and receptors, thereby tuning pathway flux. This architecture naturally explains negative control of a juxtacrine signaling axis: by binding and stabilizing extracellular or membrane-proximal complexes, the protein can dampen receptor–ligand signaling throughput. This causal chain—multivalent binding scaffold leading to pathway attenuation—maps to GO:0045746 negative regulation of Notch signaling pathway.

  4. 04

    Cellular placement follows from both the modular extracellular fold suite and the membrane-proximal annotation.

    The prealbumin/transthyretin-like and SpaA-like domains are archetypal extracellular folds, and the overall signal-sculpting role requires exposure near the cell surface. Thus, the protein operates at the membrane interface, consistent with GO:0016020 membrane, and aligns with a cell-membrane-associated, secreted/peripheral localization.

  5. 05

    Mechanistically, I hypothesize that the tandem NOMO-like domains assemble a high-avidity platform that captures cell-surface complexes involved in developmental signaling.

    By clustering and stabilizing extracellular assemblies, the scaffold attenuates Notch pathway activation—likely by constraining receptor–ligand encounter geometry or by recruiting inhibitory partners. Its ribosome-binding propensity suggests coupling to ER-associated ribosomes, coordinating co-translational folding and secretion of pathway components. Likely interaction partners include membrane-proximal signaling modules and ribosome-associated factors that together tune Notch pathway output and developmental decisions.

Technical details

InterPro entries

  • IPR013783 Immunoglobulin-like fold homologous superfamily · 122–226
  • IPR013784 Carbohydrate-binding-like fold homologous superfamily · 127–202
  • IPR013784 Carbohydrate-binding-like fold homologous superfamily · 329–403
  • IPR013784 Carbohydrate-binding-like fold homologous superfamily · 883–954
  • IPR008969 Carboxypeptidase-like, regulatory domain superfamily homologous superfamily · 964–1053
  • IPR055075 NOMO-like, N-terminal beta-sandwich domain domain · 40–124
  • IPR056189 NOMO, third transthyretin-like domain domain · 226–325
  • IPR056190 NOMO, fifth transthyretin-like domain domain · 409–498
  • IPR056319 NOMO, seventh transthyretin-like domain domain · 592–664
  • IPR056187 NOMO, eighth prealbumin-like domain domain · 746–798
  • IPR055073 NOMO-like, ninth beta-sandwich domain domain · 799–873
  • IPR041033 SpaA-like, prealbumin fold domain subgroup 1 domain · 874–955
  • IPR056191 NOMO, C-terminal transthyretin-like domain domain · 1054–1147
  • IPR051417 Serine-Aspartate Repeat-Containing family · 44–1191

Sources

Method

BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →

API

/api/v1/proteins/P69849 · API docs